A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe Programs

NAUnknownINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

December 31, 2023

Conditions
Hepatitis C, Chronic
Interventions
BEHAVIORAL

Incentive payment

Incentive payment to enhance HCV treatment uptake among people with recent injecting drug use attending needle and syringe programs.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Kirby Institute

OTHER_GOV